Back to News
Market Impact: 0.35
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookCompany Fundamentals
Abbott's Q3 earnings miss weighed on its stock, despite double-digit revenue growth and expanding margins. Lower 2026 sales guidance added to investor concerns; the article provides no figures for the miss or guidance reduction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
ABT-0.65
More News
- Stock Movers: Super Micro Computer, SpaceX, Abbot Labs (Podcast)
- Our top 10 things to watch in the stock market Wednesday
- Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
- Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide